Repligen
RGEN
#2451
Rank
A$10.80 B
Marketcap
A$191.50
Share price
-2.82%
Change (1 day)
7.86%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026A$40.06 M83.2%
2025A$21.87 M-36.33%
2024A$34.35 M-68.17%
2023A$0.10 B60.05%
2022A$67.43 M90.89%
2021A$35.32 M-76.42%
2020A$0.14 B197.63%
2019A$50.34 M-29.09%
2018A$70.99 M835.37%
2017A$7.59 M22.08%
2016A$6.21 M-19.68%
2015A$7.74 M-7.23%
2014A$8.34 M721.71%
2013A$1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
A$0.24 BA$0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$40.13 MA$95.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$0.19 BA$0.39 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$25.47 MA$84.97 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$1.32 MA$5.69 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$16.71 MA$57.53 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$92.41 MA$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.11 BA$0.13 B๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$4.78 MA$14.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$32.91 MA$0.14 B๐Ÿ‡บ๐Ÿ‡ธ USA